Pfizer vaccine for kids may not be available until November

Date:

By JONATHAN LEMIRE Associated Press

WASHINGTON (AP) — Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November.

The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old. Officials had said previously they would file an application with the FDA to authorize use in the coming weeks.

Once the company files its application, U.S. regulators and public health officials will review the evidence and consult with their advisory committees in public meetings to determine if the shots are safe and effective enough to recommend use.

That process may mean the shots may not be available until closer to Thanksgiving, according to a person familiar with the process but not authorized to discuss it publicly. But it is possible that, depending on how quickly the FDA acts, the shots could become available earlier in November, the person said.

The drugmaker and its partner, Germany’s BioNTech, say they expect to request emergency use authorization of their vaccine in children ages 5 to 11 “in the coming weeks.” The companies also plan to submit data to the European Medicines Agency and other regulators.

The two-shot Pfizer vaccine is currently available for those 12 and older. An estimated 100 million people in the U.S. have been fully vaccinated with it, according to the Centers for Disease Control and Prevention.

Pfizer tested a lower dose of the shots in children. The drugmaker said last week that researchers found the vaccine developed coronavirus-fighting antibody levels in children that were just as strong as those found in teenagers and young adults getting regular-strength doses.

Earlier this month, FDA chief Dr. Peter Marks told the AP that once Pfizer turns over its study results, his agency would evaluate the data “hopefully in a matter of weeks” to decide if the shots are safe and effective enough for younger kids.

Pfizer’s updated timetable was first reported by The Wall Street Journal.

Another U.S. vaccine maker, Moderna, also is studying its shots in elementary school-aged children. Results are expected later in the year.

Find your latest news here at the Hemet & San Jacinto Chronicle

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe to The Hemet & San Jacinto Chronicle

Popular

More like this
Related

Even the toughest fighters eventually lose the battle with time. Biden is no exception

A flashbulb memory from the archives of my life: It is the summer of 1997, and we are moving my disabled sister, Wendy, into a care home. She is in her bedroom in my parents’ house.

Riverside students get scholarships from The Aaron Norris Creative Fund

The late Aaron Norris once noted that if you’re going to serve, you’re going to give something — “your time, talent, and treasure, and that all three are equal.”

Man sentenced to 15 years to life for sexually assaulting girl in Riverside elementary school restroom

RIVERSIDE — A convicted sex offender who sexually assaulted a third grade girl inside a restroom at a Riverside elementary school was sentenced Tuesday to 15 years to life in state prison.

Mega Millions Ticket Worth $284K Sold In The Inland Empire

A Mega Millions player in the Inland Empire fell one number shy of winning the $181 million Mega Millions jackpot Tuesday